Cargando…
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population‐based series and a randomized phase III study on adjuvant chemotherapy
Current clinical algorithms are unable to precisely predict which colorectal cancer patients would benefit from adjuvant chemotherapy, and there is a need for novel biomarkers to improve the selection of patients. The metastasis‐promoting protein S100A4 predicts poor outcome in colorectal cancer, bu...
Autores principales: | Boye, Kjetil, Jacob, Havjin, Frikstad, Kari‐Anne M., Nesland, Jahn M., Mælandsmo, Gunhild M., Dahl, Olav, Nesbakken, Arild, Flatmark, Kjersti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971912/ https://www.ncbi.nlm.nih.gov/pubmed/27273130 http://dx.doi.org/10.1002/cam4.766 |
Ejemplares similares
-
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
por: Ingebrigtsen, Vibeke A, et al.
Publicado: (2014) -
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer
por: Boye, K, et al.
Publicado: (2012) -
Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-κB
por: Grotterød, Ida, et al.
Publicado: (2010) -
Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer
por: Jacob, Havjin, et al.
Publicado: (2017) -
Sensitization of interferon-γ induced apoptosis in human osteosarcoma cells by extracellular S100A4
por: Pedersen, Kjetil Boye, et al.
Publicado: (2004)